Institutional Ownership
Roivant Sciences Ltd
CUSIP G76279101SHSROIVQ1 2026
13D / 13G Filings
41
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
18.7%
Max % of class reported
Institutional Holders
430
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
41 filings · latest Mar 6, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 6, 2026 | Fmr LLC | 13G/A | 10.3% | 73.64M | SEC |
| 2 | Feb 17, 2026 | Sb Investment Advisers (Uk) Limited | 13G/A | 2.3% | 16.41M | SEC |
| 3 | Feb 13, 2026 | Ramaswamy Vivek | 13G/A | 6.8% | — | SEC |
| 4 | Feb 11, 2026 | Morgan Stanley | 13G/A | 8.0% | 55.49M | SEC |
| 5 | Feb 5, 2026 | Fmr LLC | 13G/A | 9.5% | 65.78M | SEC |
| 6 | Nov 14, 2025 | Sb Investment Advisers (Uk) Limited | 13G/A | 5.8% | 40.32M | SEC |
| 7 | Nov 14, 2025 | Viking Global Investors LP | 13G/A | 3.4% | 23.59M | SEC |
| 8 | Aug 14, 2025 | Qvt Financial LP | 13G/A | 4.3% | 29.38M | SEC |
| 9 | Aug 14, 2025 | Viking Global Investors LP | 13G/A | 5.0% | 34.24M | SEC |
| 10 | Aug 7, 2025 | Morgan Stanley | 13G | 5.5% | 37.65M | SEC |
31 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Roivant Sciences Ltd.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 77.98M | $2.16B |
| 2 | Morgan Stanley | 51.83M | $1.44B |
| 3 | Blackrock, Inc. | 44.25M | $1.23B |
| 4 | Qvt Financial LP | 25.16M | $696.97M |
| 5 | Ubs Group AG | 22.62M | $626.56M |
| 6 | State Street Corp | 16.19M | $448.37M |
| 7 | Adage Capital Partners Gp, L.L.C. | 12.79M | $354.40M |
| 8 | Goldman Sachs Group Inc | 11.11M | $307.79M |
| 9 | Geode Capital Management, LLC | 10.18M | $282.11M |
| 10 | Farallon Capital Management LLC | 9.68M | $268.00M |